Although the acute phase of the corona crisis needs all our attention, we hope that the current measures as well as new scientific insights will enable us to resume part of normal life after the summer holidays. Although it is uncertain in what format the conference can be organized, we continue with the preparation of the yearly Radboud New Frontiers. So save the date already!
In contrast with the incidental rise in communicable diseases such as COVID-2019, the prevalence of chronic, non-communicable diseases is continuously rising, and in the near future we will be unable to handle this increase. Most of these diseases are lifestyle-related. However, individuals at risk and health care professionals find it very difficult to change lifestyle. In addition, to be successful interventions need to be tailored. The best is to detect health derangements early, to intervene as early as possible, thus preventing chronicity. There are many influences on health and health behavior, requiring an optimal interaction between the individual, the healthcare system as well as the physical and social environment. In addition, there are big expectations of the role of technology, like eHealth and mHealth, in relation to prevention.
Urgent research questions arise. Should we focus on prevention of diseases, or better aim at increasing functioning and participation, despite disease? Does our current evidenced-based medicine approach, with emphasis on trials, align with the complexity of behavioral change and environmental influences?
In this Radboud New Frontiers symposium, organized by the Radboud Institute for Health Sciences (RIHS), we will address the topic of prevention research in relation to health and healthcare from various interesting, and necessary, perspectives. We will put you as clinician or researcher in the ‘action’ mode, challenged by top scientists, by asking you to think about the role prevention can have in your own research or clinical work and to discuss this with other participants.
Scientists from Europe and the United States will illustrate prevention across the lifespan, highlighting the importance of tailoring of the content and aim of prevention to the age of the individual. We will also explore the interaction between behavior and environment, and the potential role of technology in changing lifestyle. In workshops you can discuss with others what your work can contribute to health and prevention. We will wrap up with illustrations of methodological approaches that best suit the complexity of prevention and behavioral change.
This conference will give researchers and clinicians with different backgrounds and levels of seniority a broad insight into the potential of prevention for the forthcoming decades.
Save the date for 12 November 2020: Radboud New Frontiers 2020 - Prevention: the need for a leap forward.
Target audience: Master students, PhD candidates, Postdocs, senior researchers, clinicians
Related news items
Rob Aarnoutse is appointed as professor in Translation pharmacology of antimicrobial agents in particular drugs for tuberculosis25 January 2021
Hospital pharmacist and clinical pharmacologist Rob Aarnoutse is appointed as professor in ‘Translation pharmacology of antimicrobial agents, in particular drugs for tuberculosis’ at Radboud University / Radboudumc, starting 16 November 2020.read more
Oral health research makes significant impact at the 148th WHO Executive Board meeting25 January 2021
During the 148th session of the World Health Organization (WHO) Executive Board meeting, Member States passed a game-changing resolution on oral health. WHO Director General Dr Tedros Adhanom Ghebreyesus called it a “landmark resolution”.read more
Radboud Young Academy safeguards the future of science21 January 2021
New platform to provide advice on policy, create an interdisciplinary network of early career scientists, and promote career development.read more
Increase radio- and immunotherapy efficacy by targeting hypoxia21 January 2021
In a paper recently accepted by Clinical Cancer Research, Daan Boreel, together with Paul Span, Sandra Heskamp, Gosse Adema and Jan Bussink, reviews the therapeutic potential of decreasing the lack of oxygen (hypoxia) often found in solid tumors.read more
Radiation boost lowers risk of prostate cancer recurrence21 January 2021
An additional external-beam radiation dose delivered directly to the tumor can benefit the prospects of men with non-metastatic prostate cancer, without causing additional side effects. The risk of relapse within five years for these men is smaller than for men who did not receive this boost.read more
New research through grants for Radboudumc researchers14 January 2021
Several researchers at the Radboudumc have received grants to start new studies, including on rare diseases, liver disease and cancer metastases. These are grants from the Dutch Research Council, European Joint Programme on Rare Diseases and the Gastric Liver Disease Foundation.read more